The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
The Role of Ethnicity in Variability in Response to Drugs: Focus on Clinical Pharmacology Studies
Abstract
Ethnicity is one factor that may account for the observed differences in both pharmacokinetics (PK) and pharmacodynamics (PD) of drugs, resulting in variability in response to drug therapy. Given that the applicability of clinical study results to the treatment of an individual patient is a critical consideration in a physician's choice of drug therapy, drug development should seek to ensure that a clinical pharmacologic evaluation includes a population that is representative of the target therapeutic population. Ethnic diversity in drug response with respect to safety and efficacy and the resulting differences in recommended doses have been well described for some drugs. Some of these differential responses may be related to the pharmacogenomics of a particular drug. Pharmacogenomic techniques have recently enjoyed widespread use in studies of drug exposure and response. The clinical relevance of variability in drug response due to pharmacogenomics of drug-metabolizing enzymes was considered at a September 2004 workshop cosponsored by the US Food and Drug Administration (FDA), Johns Hopkins University, and the Pharmaceutical Research and Manufacturers of America (http://www.fda.gov/cder/Offices/OCPB/workshops.htm).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A marker for Stevens–Johnson syndrome
Chung, W.-H., Hung, S.-I., Hong, H.-S., Hsih, M.-S., Yang, L.-C., Ho, H.-C., Wu, J.-Y., & Chen, Y.-T. (2004) · Nature · doi:10.1038/428486a · Cited by 1,753
Bjornsson, T. D., Callaghan, J. T., Einolf, H. J., Fischer, V., Gan, L., Grimm, S., Kao, J., King, S. P., Miwa, G., Ni, L., et al. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.7.815 · Cited by 792
Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions
Hung, S.-I., Chung, W.-H., Jee, S.-H., Chen, W.-C., Chang, Y.-T., Lee, W.-R., Hu, S.-L., Wu, M.-T., Chen, G.-S., Wong, T.-W., et al. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000199500.46842.4a · Cited by 680
Drug Interaction Studies: Study Design, Data Analysis, and Implications for Dosing and Labeling
Huang, S.-M., Temple, R., Throckmorton, D. C., & Lesko, L. J. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100054 · Cited by 579
Self-citationLang, T., Klein, K., Fischer, J., Nussler, A. K., Neuhaus, P., Hofmann, U., Eichelbaum, M., Schwab, M. G., & Zanger, U. M. (2001) · Pharmacogenetics · doi:10.1097/00008571-200107000-00004 · Cited by 574
Yuan, H.-Y., Chen, J.-J., Lee, M. T. M., Wung, J.-C., Chen, Y.-F., Charng, M.-J., Lu, M.-J., Hung, C.-R., Wei, C.-Y., Chen, C.-H., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi180 · Cited by 486
LEE, E., RYAN, S., BIRMINGHAM, B., ZALIKOWSKI, J., MARCH, R., AMBROSE, H., MOORE, R., LEE, C., CHEN, Y., & SCHNECK, D. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.06.013 · Cited by 480
Kroetz, D. L., Pauli-Magnus, C., Hodges, L. M., Huang, C. C., Kawamoto, M., Johns, S. J., Stryke, D., Ferrin, T. E., DeYoung, J., Taylor, T., et al. (2003) · Pharmacogenetics · doi:10.1097/00008571-200308000-00006 · Cited by 429
Pharmacogenomics of human OATP transporters
König, J., Seithel, A., Gradhand, U., & Fromm, M. F. (2006) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-006-0040-y · Cited by 357
Schoedel, K. A., Hoffmann, E. B., Rao, Y., Sellers, E. M., & Tyndale, R. F. (2004) · Pharmacogenetics · doi:10.1097/00008571-200409000-00006 · Cited by 315
Bernard, S., Neville, K. A., Nguyen, A. T., & Flockhart, D. A. (2006) · The Oncologist · doi:10.1634/theoncologist.11-2-126 · Cited by 277
Zamber, C. P., Lamba, J. K., Yasuda, K., Farnum, J., Thummel, K., Schuetz, J. D., & Schuetz, E. G. (2003) · Pharmacogenetics · doi:10.1097/00008571-200301000-00004 · Cited by 272
Klein, K., Lang, T., Saussele, T., Barbosa-Sicard, E., Schunck, W.-H., Eichelbaum, M., Schwab, M., & Zanger, U. M. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200512000-00004 · Cited by 269
Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6
Kirchheiner, J., Klein, C., Meineke, I., Sasse, J., Zanger, U. M., M??rdter, T. E., Roots, I., & Brockm??ller, J. (2003) · Pharmacogenetics · doi:10.1097/00008571-200310000-00005 · Cited by 249
Limdi, N., McGwin, G., Goldstein, J., Beasley, T., Arnett, D., Adler, B., Baird, M., & Acton, R. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100290 · Cited by 248
Bhasker, C. R., McKinnon, W., Stone, A., Lo, A. C., Kubota, T., Ishizaki, T., & Miners, J. O. (2000) · Pharmacogenetics · doi:10.1097/00008571-200011000-00002 · Cited by 245
Myrand, S., Sekiguchi, K., Man, M., Lin, X., Tzeng, R.-Y., Teng, C.-H., Hee, B., Garrett, M., Kikkawa, H., Lin, C.-Y., et al. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100482 · Cited by 224
NAKAJIMA, M., FUKAMI, T., YAMANAKA, H., HIGASHI, E., SAKAI, H., YOSHIDA, R., KWON, J., MCLEOD, H., & YOKOI, T. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.05.012 · Cited by 222
The pharmacokinetics and metabolic disposition of tacrolimus: A comparison across ethnic groups
Mancinelli, L. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113183 · Cited by 206
Ho, R. H., Choi, L., Lee, W., Mayo, G., Schwarz, U. I., Tirona, R. G., Bailey, D. G., Michael Stein, C., & Kim, R. B. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3280ef698f · Cited by 199
CYP3A5 GENETIC POLYMORPHISMS IN DIFFERENT ETHNIC POPULATIONS
Roy, J.-N., Lajoie, J., Zijenah, L. S., Barama, A., Poirier, C., Ward, B. J., & Roger, M. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.003822 · Cited by 182
Interethnic and Intraethnic Variability of CYP2C8 and CYP2C9 Polymorphisms in Healthy Individuals
García‐Martín, E., Martínez, C., Ladero, J. M., & Agúndez, J. A. G. (2006) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256440 · Cited by 157
Drug-metabolizing enzymes: Evidence for clinical utility of pharmacogenomic tests
ANDERSSON, T., Flockhart, D. A., Goldstein, D. A., Huang, S. M., Kroetz, D. L., Milos, P. M., Ratain, M. J., & Thummel, K. E. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.08.013 · Cited by 153
Self-citationA Review and Assessment of Potential Sources of Ethnic Differences in Drug Responsiveness
Bjornsson, T. D., Wagner, J. A., Donahue, S., Harper, D. M., Karim, A., Khouri, M. S., Murphy, W. R. C., Roman, K., Schneck, D. W., Sonnichsen, D. S., et al. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003256065 · Cited by 147
Pasanen, M. K., Backman, J. T., Neuvonen, P. J., & Niemi, M. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-006-0123-1 · Cited by 119
PhRMA White Paper on ADME Pharmacogenomics
Williams, J. A., Andersson, T., Andersson, T. B., Blanchard, R. L., Behm, M. O., Cohen, N., Edeki, T. I., Franc, M. A., Hillgren, K. M., Johnson, K. J., et al. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008319329 · Cited by 69
Liu, J. Y., Qu, K. Z., Sferruzza, A. D., & Bender, R. A. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32803a46fe · Cited by 59
Organic anion transporting polypeptide-1B1 haplotypes in Chinese patients
Xu, L., He, Y., Zhang, W., Deng, S., Li, Q., Zhang, W., Liu, Z., Wang, D., Huang, Y., Zhou, H., et al. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00643.x · Cited by 41
Kim, K., Birmingham, B., Azumaya, C. T., Zalikowski, J. A., Chen, Y., & Schneck, D. W. (2008) · Cited by 10
Cited by
Volgman, A. S., Palaniappan, L. S., Aggarwal, N. T., Gupta, M., Khandelwal, A., Krishnan, A. V., Lichtman, J. H., Mehta, L. S., Patel, H. N., Shah, K. S., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000580 · Cited by 552
Racial/ethnic differences in drug disposition and response: Review of recently approved drugs
Ramamoorthy, A., Pacanowski, M., Bull, J., & Zhang, L. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.61 · Cited by 341
Self-citationHolland, A. T., & Palaniappan, L. P. (2012) · Annals of Epidemiology · doi:10.1016/j.annepidem.2012.04.001 · Cited by 300
Drug-microbiota interactions: an emerging priority for precision medicine
Zhao, Q., Chen, Y., Huang, W., Zhou, H., & Zhang, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01619-w · Cited by 268
Cancer Pharmacoethnicity: Ethnic Differences in Susceptibility to the Effects of Chemotherapy
O'Donnell, P. H., & Dolan, M. E. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0344 · Cited by 261
Metadata
- Authors
- Yasuda, S., Zhang, L., & Huang, S.-M.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2008-07-09
- Volume
- 84
- Issue
- 3
- Pages
- 417-423
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2055457865
- Cited by
- 393
- References
- 29
- FWCI
- 6.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.